To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

Bill: 118-hr-4490
Sponsor: full_name: Rep. Guthrie, Brett [R-KY-2]
Introduced: 2023-07-06
Policy area: Health
Subjects: Drug trafficking and controlled substances

Health personnel

Prescription drugs
Latest action: action_date: 2023-07-07
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-07-06
action_desc: Introduced in House
text: <p>This bill broadens the authority of pharmacies under the Controlled Substances Act to deliver certain controlled substances to health care practitioners for the purpose of administering the substance to a patient.</p><p>Under current law, pharmacies may deliver controlled substances in schedules III, IV, or V to a practitioner if it is for maintenance or detoxification treatment and is administered via injection or implantation, among other requirements. The bill applies this authority to any controlled substance in schedules III, IV, or V that is approved by the Food and Drug Administration to be administered by, or under the supervision of, a practitioner.</p>

tv_txt: I 118th CONGRESS 1st Session H. R. 4490 IN THE HOUSE OF REPRESENTATIVES July 6, 2023 Mr. Guthrie (for himself, Ms. Matsui , and Ms. Kuster ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

1. Delivery of certain substances by a pharmacy to an administering practitioner Paragraph (2) of section 309A(a) of the Controlled Substances Act ( 21 U.S.C. 829a(a) ) is amended to read as follows: (2) the controlled substance is a drug in schedule III, IV, or V that is, pursuant to the approval or licensure of such drug under the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act, to be administered by, or under the supervision of, the practitioner; .